21. November 2009 01:40
We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines.
[More]
20. November 2009 04:39
Research and Markets (http://www.researchandmarkets.com/research/fae4d4/neurological_disea) has announced the addition of Decision Resources, Inc.'s new report "Neurological Disease: Early-Stage R&D and Dealmaking" to their offering.
[More]
20. November 2009 04:22
Between 17-21 October 2009, the 39th annual conference of the Society of Neuroscience drew some 30,500 people to the great city of Chicago, which was more balmy than windy for the occasion. Your Alzforum reporters have been busy roaming the halls, buttonholing scientists for their comments on the presentations, and putting together reports on the most significant advances.
[More]
20. November 2009 03:16
Research and Markets (http://www.researchandmarkets.com/research/60b63b/the_pricing_and_re) has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering.
[More]
20. November 2009 00:24
For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. In fact, the researchers were not able to detect any long-term cognitive declines attributable to surgery in a group of 575 patients they studied.
[More]
19. November 2009 23:57
Research and Markets (http://www.researchandmarkets.com/research/5f3158/alzheimers_and_pa) has announced the addition of the "Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities" report to their offering.
[More]
19. November 2009 05:33
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
[More]
19. November 2009 04:41
A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome.
[More]
19. November 2009 03:26
Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease?
[More]
d04deaf6-9ae4-4f7b-ac41-7cda8819e08c|0|.0
Posted in: Medical Condition News | Miscellaneous News
Tags: Alzheimer's Disease, beta Amyloid, Cancer, Cell, Diabetes, Diet, Education, Glucose Metabolism, Hospital, Insulin, Metabolism, Neuroscience, Oxidative Stress, Paralysis, Pathology, Stress
19. November 2009 02:36
Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking.
[More]
b8645f7a-360b-4e84-8d26-80c779fd4e42|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Anti-Inflammatory, Atrial Fibrillation, Blood Pressure, Blood Vessel, Brain, Cholesterol, Dementia, Diabetes, Exercise, Kidney Disease, Nervous System, Seniors, Sleep, Statin
19. November 2009 02:13
Dr. Donald Weaver, a Halifax researcher with unmatched credentials, received the Prix Galien Research Award at a ceremony in Ottawa last night. Known as the Nobel Prize of pharmaceutical research, this award is the highest distinction worldwide for biopharmaceutical work, and the most prestigious in the field of Canadian pharmaceutical research and innovation.
[More]
19. November 2009 01:42
Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries.
[More]
234d5eb2-35a6-4162-8012-1ce935422d94|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Acne, Alzheimer's Disease, Dermatology, Diarrhea, Dystonia, Headache, Hygiene, Hypercholesterolemia, Hyperglycemia, Neurology, Parkinson's Disease, Podiatry, Stroke, Tinnitus
19. November 2009 00:55
There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS.
[More]
88745bdd-ced7-4029-aac6-087acf42e621|0|.0
Posted in: Medical Condition News | Women's Health News
Tags: Alzheimer's Disease, Blood Pressure, Brain, Diabetes, Epilepsy, Gestational Diabetes, Multiple Sclerosis, Nervous System, Neurology, Neuroscience, Parkinson's Disease, Pregnancy, Stroke, Ultrasound
18. November 2009 07:00
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
[More]
c173918c-001b-4fb8-a3fe-2aa87ea54632|1|5.0
Posted in: Medical Science News | Medical Condition News
Tags: Alzheimer's Disease, Biochemistry, Brain, Cell, Embryonic Stem Cell, Gene Expression, Hospital, Nervous System, Neuron, Parkinson's Disease, Stem Cell
18. November 2009 04:11
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
[More] 
Subscribe